Thus, the ANO1 inhibitor identified here constitutes new and readily accessible chemical tool for pharmacological dissection of ANO1 and may be a potential development candidate for drug therapy of cancer, hypertension, pain, diarrhea, asthma and other ANO1 related diseases. Here, ANO1 is linked to hypertensive disorder.